Widely followed crypto analyst Michaël van de Poppe Ethereum (ETH) rival Avalanche (AVAX) and the decentralized exchange protocol Injective (INJ) announced that it expects a rally.
Van de Poppe tells his 636,000 Twitter followers that AVAX is starting to rise as the RSI (relative strength indicator) continues to rise as the price continues to drop. told. According to the analyst, this is a bullish signal and indicates that buyers are starting to gather strength.
“Positive Divergence” (Bullish Divergence), I expect a reversal targeting $17 and potentially $20 as the markets move.”
Koinfinans.com As we have reported, the “Positive Divergence” (Bullish Divergence) mentioned by Van de Poppe means that the indicator rises while the price continues to fall.
Van de Poppe, who also reviewed Injective, thinks that INJ’s short correction period is coming to an end.
“Yes, INJ took a hit in this area and bounced strong. Imagine if the markets finished this correction today/tomorrow and turned up again, then this (altcoin) will show strength.”
Another altcoin on the analyst’s radar Ripple (XRP). If XRP manages to hold support at $0.44, the crypto analyst says the altcoin could potentially bounce back into the $0.51 high range. is thinking.
“It’s back to low range and support, but the second test here usually doesn’t provide power. Still good for long position. If support is lost -> $0.40 is the next area.”
The last altcoin the analyst followed is Ethereum rival Near Protocol (NEAR). According to Van de Poppe, NEAR bulls must retake a significant level to avoid a drop. Otherwise, the smart contract platform may continue to decline.
“As it has been a bearish retest so far, retrieving $3.10 activates a continuation to $4.”
You can follow the current price action here.
Disclaimer: What is written here is not investment advice. Cryptocurrency investments are high-risk investments. Every investment decision is under the individual’s own responsibility. Finally, Koinfinans and the author of this content cannot be held responsible for personal investment decisions.